ID   CD2AP_RAT               Reviewed;         637 AA.
AC   F1LRS8; Q7TSS5;
DT   22-JAN-2014, integrated into UniProtKB/Swiss-Prot.
DT   22-JAN-2014, sequence version 2.
DT   24-JUL-2024, entry version 87.
DE   RecName: Full=CD2-associated protein;
GN   Name=Cd2ap;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Kawachi H., Koike H., Shimizu F.;
RT   "Rat CD2AP.";
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   FUNCTION IN RET STABILITY, INTERACTION WITH CBLC AND RET, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=18753381; DOI=10.1523/jneurosci.2738-08.2008;
RA   Tsui C.C., Pierchala B.A.;
RT   "CD2AP and Cbl-3/Cbl-c constitute a critical checkpoint in the regulation
RT   of ret signal transduction.";
RL   J. Neurosci. 28:8789-8800(2008).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458; SER-469; SER-510 AND
RP   SER-514, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Seems to act as an adapter protein between membrane proteins
CC       and the actin cytoskeleton (By similarity). In collaboration with CBLC,
CC       modulates the rate of RET turnover and may act as regulatory checkpoint
CC       that limits the potency of GDNF on neuronal survival. Controls CBLC
CC       function, converting it from an inhibitor to a promoter of RET
CC       degradation (PubMed:18753381). May play a role in receptor clustering
CC       and cytoskeletal polarity in the junction between T-cell and antigen-
CC       presenting cell (By similarity). May anchor the podocyte slit diaphragm
CC       to the actin cytoskeleton in renal glomerolus. Also required for
CC       cytokinesis. Plays a role in epithelial cell junctions formation (By
CC       similarity). {ECO:0000250|UniProtKB:Q9JLQ0,
CC       ECO:0000250|UniProtKB:Q9Y5K6, ECO:0000269|PubMed:18753381}.
CC   -!- SUBUNIT: Homodimer. Interacts with F-actin, PKD2, NPHS1 and NPHS2.
CC       Interacts with WTIP. Interacts with DDN; interaction is direct.
CC       Interacts (via SH3 2 domain) with CBL (via phosphorylated C-terminus).
CC       Interacts with BCAR1/p130Cas (via SH3 domain). Interacts with MVB12A
CC       and ARHGAP17. Interacts with ANLN, CD2 and CBLB. Interacts with PDCD6IP
CC       and TSG101. Interacts with RIN3. Interacts directly with RET (inactive)
CC       and CBLC; upon RET activation by GDNF suggested to dissociate from RET
CC       as CBLC:CD2AP complex. Interacts with CGNL1 and SH3BP1; probably part
CC       of a complex at cell junctions. Interacts with CAPZA1.
CC       {ECO:0000250|UniProtKB:Q9Y5K6, ECO:0000269|PubMed:18753381,
CC       ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q9Y5K6}. Cell projection, ruffle
CC       {ECO:0000250|UniProtKB:Q9Y5K6}. Cell junction
CC       {ECO:0000250|UniProtKB:Q9Y5K6}. Note=Colocalizes with F-actin and
CC       BCAR1/p130Cas in membrane ruffles (By similarity). Located at podocyte
CC       slit diaphragm between podocyte foot processes (By similarity). During
CC       late anaphase and telophase, concentrates in the vicinity of the
CC       midzone microtubules and in the midbody in late telophase (By
CC       similarity). {ECO:0000250|UniProtKB:Q9JLQ0,
CC       ECO:0000250|UniProtKB:Q9Y5K6}.
CC   -!- TISSUE SPECIFICITY: Expressed in neurons and renal glomerular podocytes
CC       (at protein level). {ECO:0000269|PubMed:18753381}.
CC   -!- DOMAIN: The Pro-rich domain may mediate binding to SH3 domains.
CC       {ECO:0000250}.
CC   -!- DOMAIN: Potential homodimerization is mediated by the coiled coil
CC       domain. {ECO:0000250}.
CC   -!- PTM: Phosphorylated on tyrosine residues; probably by c-Abl, Fyn and c-
CC       Src. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY114147; AAM47029.1; -; mRNA.
DR   EMBL; AABR06058949; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06058950; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06058951; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; F1LRS8; -.
DR   SMR; F1LRS8; -.
DR   CORUM; F1LRS8; -.
DR   IntAct; F1LRS8; 1.
DR   STRING; 10116.ENSRNOP00000016291; -.
DR   iPTMnet; F1LRS8; -.
DR   PhosphoSitePlus; F1LRS8; -.
DR   jPOST; F1LRS8; -.
DR   PaxDb; 10116-ENSRNOP00000016291; -.
DR   Ensembl; ENSRNOT00055034475; ENSRNOP00055027936; ENSRNOG00055020135.
DR   Ensembl; ENSRNOT00060038690; ENSRNOP00060031945; ENSRNOG00060022056.
DR   Ensembl; ENSRNOT00065044448; ENSRNOP00065036439; ENSRNOG00065025630.
DR   AGR; RGD:727803; -.
DR   RGD; 727803; Cd2ap.
DR   VEuPathDB; HostDB:ENSRNOG00000011987; -.
DR   eggNOG; KOG4348; Eukaryota.
DR   HOGENOM; CLU_024255_2_0_1; -.
DR   InParanoid; F1LRS8; -.
DR   OrthoDB; 2972088at2759; -.
DR   TreeFam; TF350191; -.
DR   PRO; PR:F1LRS8; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000011987; Expressed in stomach and 18 other cell types or tissues.
DR   GO; GO:0005884; C:actin filament; ISO:RGD.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0031252; C:cell leading edge; IDA:RGD.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:RGD.
DR   GO; GO:0031941; C:filamentous actin; ISO:RGD.
DR   GO; GO:0030426; C:growth cone; ISO:RGD.
DR   GO; GO:0005770; C:late endosome; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0005641; C:nuclear envelope lumen; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0002102; C:podosome; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0001726; C:ruffle; ISO:RGD.
DR   GO; GO:0036057; C:slit diaphragm; ISO:RGD.
DR   GO; GO:0032588; C:trans-Golgi network membrane; ISO:RGD.
DR   GO; GO:0031982; C:vesicle; ISO:RGD.
DR   GO; GO:0003779; F:actin binding; ISO:RGD.
DR   GO; GO:0051015; F:actin filament binding; ISO:RGD.
DR   GO; GO:0008013; F:beta-catenin binding; IDA:RGD.
DR   GO; GO:0045296; F:cadherin binding; IPI:RGD.
DR   GO; GO:0030276; F:clathrin binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0036312; F:phosphatidylinositol 3-kinase regulatory subunit binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0017124; F:SH3 domain binding; ISO:RGD.
DR   GO; GO:0005172; F:vascular endothelial growth factor receptor binding; IDA:RGD.
DR   GO; GO:0007015; P:actin filament organization; ISS:UniProtKB.
DR   GO; GO:0030041; P:actin filament polymerization; ISO:RGD.
DR   GO; GO:0060612; P:adipose tissue development; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; ISO:RGD.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0016477; P:cell migration; IMP:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; IMP:RGD.
DR   GO; GO:0044331; P:cell-cell adhesion mediated by cadherin; ISO:RGD.
DR   GO; GO:0045216; P:cell-cell junction organization; ISO:RGD.
DR   GO; GO:0048668; P:collateral sprouting; ISO:RGD.
DR   GO; GO:0003158; P:endothelium development; ISO:RGD.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0046847; P:filopodium assembly; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0032835; P:glomerulus development; ISO:RGD.
DR   GO; GO:0046323; P:glucose import; ISO:RGD.
DR   GO; GO:0001771; P:immunological synapse formation; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   GO; GO:0006629; P:lipid metabolic process; ISO:RGD.
DR   GO; GO:0001889; P:liver development; ISO:RGD.
DR   GO; GO:0051674; P:localization of cell; ISO:RGD.
DR   GO; GO:0048535; P:lymph node development; ISO:RGD.
DR   GO; GO:0035633; P:maintenance of blood-brain barrier; ISO:RGD.
DR   GO; GO:0008584; P:male gonad development; ISO:RGD.
DR   GO; GO:0061024; P:membrane organization; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0051058; P:negative regulation of small GTPase mediated signal transduction; ISS:UniProtKB.
DR   GO; GO:0032911; P:negative regulation of transforming growth factor beta1 production; ISO:RGD.
DR   GO; GO:0038180; P:nerve growth factor signaling pathway; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.
DR   GO; GO:0038179; P:neurotrophin signaling pathway; ISO:RGD.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; ISO:RGD.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0072112; P:podocyte differentiation; ISO:RGD.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; ISO:RGD.
DR   GO; GO:0050714; P:positive regulation of protein secretion; ISO:RGD.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:RGD.
DR   GO; GO:0030163; P:protein catabolic process; ISO:RGD.
DR   GO; GO:0051291; P:protein heterooligomerization; ISO:RGD.
DR   GO; GO:0009306; P:protein secretion; ISO:RGD.
DR   GO; GO:0015031; P:protein transport; ISO:RGD.
DR   GO; GO:0032482; P:Rab protein signal transduction; ISO:RGD.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0048259; P:regulation of receptor-mediated endocytosis; IDA:RGD.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISO:RGD.
DR   GO; GO:0097018; P:renal albumin absorption; ISO:RGD.
DR   GO; GO:1990790; P:response to glial cell derived neurotrophic factor; ISO:RGD.
DR   GO; GO:0032868; P:response to insulin; ISO:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; ISO:RGD.
DR   GO; GO:0071559; P:response to transforming growth factor beta; ISO:RGD.
DR   GO; GO:0009615; P:response to virus; ISO:RGD.
DR   GO; GO:0009611; P:response to wounding; ISO:RGD.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; ISO:RGD.
DR   GO; GO:0050808; P:synapse organization; ISO:RGD.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0032905; P:transforming growth factor beta1 production; ISO:RGD.
DR   GO; GO:0016050; P:vesicle organization; IDA:RGD.
DR   CDD; cd12053; SH3_CD2AP_1; 1.
DR   CDD; cd12054; SH3_CD2AP_2; 1.
DR   CDD; cd12056; SH3_CD2AP_3; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 3.
DR   InterPro; IPR035775; CD2AP_SH3_1.
DR   InterPro; IPR035777; CD2AP_SH3_3.
DR   InterPro; IPR035776; CD2AP_SH_2.
DR   InterPro; IPR050384; Endophilin_SH3RF.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR14167:SF92; CIN85 AND CD2AP RELATED, ISOFORM J; 1.
DR   PANTHER; PTHR14167; SH3 DOMAIN-CONTAINING; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   Pfam; PF14604; SH3_9; 2.
DR   PRINTS; PR00499; P67PHOX.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 3.
DR   SUPFAM; SSF50044; SH3-domain; 3.
DR   PROSITE; PS50002; SH3; 3.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Cell junction; Cell projection; Coiled coil;
KW   Cytoplasm; Cytoskeleton; Isopeptide bond; Mitosis; Phosphoprotein;
KW   Reference proteome; Repeat; SH3 domain; SH3-binding; Ubl conjugation.
FT   CHAIN           1..637
FT                   /note="CD2-associated protein"
FT                   /id="PRO_0000424877"
FT   DOMAIN          1..59
FT                   /note="SH3 1; truncated"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          108..167
FT                   /note="SH3 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          269..330
FT                   /note="SH3 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          1..175
FT                   /note="Interaction with ANLN and localization to the
FT                   midbody"
FT                   /evidence="ECO:0000250"
FT   REGION          167..211
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          333..455
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          488..556
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          580..635
FT                   /evidence="ECO:0000255"
FT   MOTIF           336..352
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           378..397
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           410..422
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        358..377
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        411..425
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        441..455
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        518..533
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         80
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y5K6"
FT   MOD_RES         86
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y5K6"
FT   MOD_RES         224
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y5K6"
FT   MOD_RES         458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         469
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         510
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         514
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         580
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y5K6"
FT   CROSSLNK        58
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y5K6"
FT   CROSSLNK        523
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y5K6"
FT   CONFLICT        169
FT                   /note="D -> E (in Ref. 1; AAM47029)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        185
FT                   /note="T -> S (in Ref. 1; AAM47029)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        450
FT                   /note="E -> D (in Ref. 1; AAM47029)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   637 AA;  70491 MW;  772F9EDFF65BA19B CRC64;
     MVDYIVEYDY DAVHDDELTI RVGEIIRNVK KLQEEGWLEG ELNGRRGMFP DNFVKEIKRE
     TEPKDDNLPI KRERPGNVAS LVQRISTYGL PAGGIQPHPQ TKAMKKKTKK RQCKVLFEYS
     PQNEDELELT VGDVIDVIEE VEEGWWSGTL NNKLGLFPSN FVKELESTDD GEMHDAQEES
     EVSLTGPTSP MPSPGNGSEP APGSVTQPKK IRGVGFGDIF KEGSVKLRTR TSSSETEEKK
     SEKPLILQSL GSRTQNVEVT KPDIDGKIKA KEYCKTVFPY TGTNEDELTF REGEIIHLIS
     KETGEAGWWK GELNGKEGVF PDNFAVQISE LDKDFPKPKK PPPPAKGPAP KPDPLAGEKK
     TFPLKAEDRD EKSLLEQKPS KPAAPQVPPK KPTPPTKANN LLRSPGTMYP KRPEKPVPPP
     PPTAKINGEV STISSKIDTE PLSKPKLDPE QLPVRPKSVD LDALVARNSK ETDNVNFDDI
     ASSENLLHLT ANRPKMPGRR LPGRFNGGHS PTQSPEKTLK LPKDDDSGNI KPSEFKKDAG
     YSSKPSLSAP SSASKVNTAA FLSPLELKAK VEADDGKKSS LDELRAQIIE LLCIVDALKK
     DHGKELEKLR RELEEEKAMR SNLEVEIAKL KKAVLLS
//
